November 17 | Speakers
The past several years have shown a growing display of robotic innovation in healthcare. Startup effort in the space has been grand, but to truly be able to change medicine, buy-in from all industry players is required. What does the integration of robotics in healthcare mean for providers? What issues can adoption of the technology solve? Which have they solved to date? Join us as these leaders detail the collaborative feedback process to drive meaningful innovation in healthcare robotics.
Moderator: Will Morris, MD,
Executive Medical Director, Cleveland Clinic
Dr. William Morris is the Executive Medical Director of Cleveland Clinic Innovations. Dr. Morris has been a staff member of Hospital Medicine at Cleveland Clinic since 2006. In his former role as Associate Chief Information Officer he had oversight of design, development, and deployment of all clinical IT systems and health IT innovations. Dr. Morris also continues to practice medicine, and in 2017 was elected to Board of Governors on which he currently serves.
Dr. Morris earned his medical degree from Case Western Reserve University School of Medicine and completed training in Internal Medicine at Beth Israel Deaconess Medical Center, Harvard Medical School. He also received his MBA in 2017 from Case Western Reserve University Weatherhead School of Management.
Bob DeSantis is Executive Vice President and General Manager of Instruments, Accessories, and Endoscopes (I, A & E) at Intuitive. He leads the global teams that design, manufacture, and market a portfolio of products that enable customers to achieve better outcomes for patient populations around the world.
Mr. DeSantis joined Intuitive in 2013 as Vice President, Instruments & Accessories New Product Introduction. His role was later expanded to include leading the product development, marketing, engineering, and operations teams for the instruments, accessories, and endoscope portfolios. DeSantis has also played a key role in the expansion and scaling of Intuitive’s manufacturing global operations.
DeSantis started his career at U.S. Surgical where he was part of the research team that developed laparoscopic technologies that enabled the first wave of minimally invasive surgery. Later as part of Covidien, he served as as VP of R&D for Surgical Devices leading the mechanical and energy devices organizations. He also led the group that developed and first commercialized single incision laparoscopic surgery (SILS).
DeSantis earned a B.S. and M.S. in Mechanical Engineering from the State University of New York, Buffalo. He also holds a Certificate in Innovation Management from the Massachusetts Institute of Technology.
Jihad Kaouk, MD,
Director, Center for Laparoscopic and Robotic Surgery, Cleveland Clinic
Jihad H. Kaouk, M.D. is an Associate Professor of Surgery and the Director of the Center
for Advanced Laparoscopic and Robotic Surgery in the Glickman Urological & Kidney
Institute at Cleveland Clinic. He is a leader in the development of innovative surgical
techniques and specializes in robotics and laparoscopic surgery and he is an expert in
kidney ablative therapies.
Dr. Kaouk developed a new surgical approach at Cleveland Clinic, known as single-port laparoscopy, that result in little or no scarring after surgery and reduces complications and pain that commonly occurs after traditional open and even minimally invasive abdominal surgery. Dr. Kaouk and his team performed more than 120 cases of various kidney and pelvic pathologies using this novel surgical technique. Recently, Dr. Kaouk successfully used the surgical robot to perform the first human applications of robotic single port surgery that was published in peer reviewed urology journals.
Dr. Kaouk received the Cleveland Clinic Innovator Award in 2006 for innovative techniques for robotic radical prostatectomy and sural nerve grafting. In addition, he was named in Who’s Who in America and one of America’s Top Physicians in Urology by Consumers’ Research Council from 2005-2007.
Dr. Kaouk received First Prize in the 18th World Congress on Endourology in Sao Paulo, Brazil, for his work on laparoscopic removal of bladder and intracorporeal urinary diversion. He also received the best overall research paper award at the 26th World Congress on Endourology in Shanghai for his work on single port laparoscopy.
Dr. Kaouk received his undergraduate degree from the American University of Beirut in Beirut, Lebanon, and medical degree from the American University of Beirut Faculty of Medicine (AUB). Dr. Kaouk completed his fellowship in advanced laparoscopy and conducted research in minimally invasive surgery at Cleveland Clinic. He was appointed
to Cleveland Clinic staff in 2002.
Dr. Kaouk has authored 147 peer-reviewed publications and 12 book chapters. He has published on several innovations including single port laparoscopic surgery and various robotic urologic procedures. Dr. Kaouk is a member of the American Urological Association and Endourological Society and serves on an American Urologic Association committee of guidelines for the management of small renal tumors.
Chief Strategy & Technology Officer, Ximedica
As Chief Strategy and Technology of Ximedica, Michael focuses on developing strategies that help Ximedica’s clients and partners successfully meet their company missions. Michael focuses on supporting clients on how to best manage the right mix of business, technology and portfolio needs understanding budgetary and time constraints, while developing great products.
Michael leads Ximedica’ s design, product development and manufacturing sector leadership teams, ensuring the proper direction of programs and that our client's needs and the program's overall goals are achieved. Michael emphasizes Ximedica’s philosophy of cross-functional collaboration with our clients and being accountable to delivering superior products that make a difference.
Michael has over 25 years of product development and manufacturing experience and has been at Ximedica for over 20 years. During his tenure at Ximedica, he has been involved in the development of hundreds of medical and consumer products in a variety of roles, including Lead Engineer, Program Manager, and Head of Program Management and Engineering.
In addition to his responsibilities within Ximedica, Michael presents at a variety of industry events on how to successfully commercialize great medical products.
Chief Operating Officer, Corindus
Doug is a forward-thinking medical device executive with a 20+-year track record of driving operational excellence for research and product development organizations. He has contributed millions to top- and bottom-line growth of companies through operational improvement and implementation of emerging and disruptive technologies. Since joining Corindus in 2016, Doug has transformed the organization into a fast-growing, healthcare robotics company aimed at disrupting the current care model for stroke and heart attack. He has positioned Corindus as the global leader in vascular robotics through development of a second-generation robotic system and advanced capabilities in procedural automation and telerobotics. Under Doug’s leadership in 2018, Corindus completed the world’s first-in-human remote robotic interventional heart procedure. That was followed by the first in-human robotic neurovascular intervention in 2019. Prior to joining Corindus, Doug served as Vice President in Boston Scientific’s development organization, responsible for strategy and operations of its global clinical and preclinical research functions. He played a key role in returning BSC to profitability and growth by accelerating pivotal cardiovascular development programs and improving multiple large-scale laboratory and research facilities. Doug holds a Master of Science and Bachelor’s degree from Purdue University and served as an Engineer in the United States Army Reserves.
Vice President & General Manager, Worldwide Robotics, Zimmer Biomet
Liane Teplitsky is the Vice President and General Manager of Worldwide Robotics at Zimmer Biomet, a global leader in musculoskeletal healthcare. A 20-year veteran of the medical technology industry, Liane is responsible for leading the global growth and development of Zimmer Biomet’s portfolio of, which includes the ROSA Robotics systems and mymobility®
with Apple Watch®
, a state-of-the-art remote patient monitoring and data informatics platform.
With a solid background in R&D and a passion for advancing intelligent and life-changing medical technologies, Liane has cultivated a seasoned expertise in leading business strategy, clinical data development and commercialization for multimillion-dollar global medical technology franchises. Prior to Zimmer Biomet, Liane spent nearly a decade in executive leadership roles at Abbott and St. Jude Medical, with a focus on cardiac diseases and diagnostics.
Liane holds a Master of Science in Biomedical Engineering from Duke University, and a Bachelor of Science Electrical Engineering and a Bachelor of Science in Physiology from the University of Saskatchewan.
An avid swimmer and runner, Liane lives in Park City, Utah with her husband, Edwin, and her two sons, Everett (8) and Spencer (6).